Related News
Berizzo hit by prostate tumor news
Print Edition
A DAY after Sevilla rallied to hold Liverpool to a remarkable 3-3 draw in the UEFA Champions League, the Spanish club said coach Eduardo “Toto” Berizzo has a malignant tumor.
Rumors about the coach’s condition began spreading not long after Tuesday’s match in Seville. Yesterday, the club confirmed that the 48-year-old Argentine has been diagnosed with a prostate tumor.
Sevilla’s mantra of “Never Give Up” was extensively brought up by fans and players after the club pulled off its comeback against Liverpool with an injury-time goal by Guido Pizarro. It was brought up again yesterday.
“You are in the best place in the world to never give up,” former Sevilla sporting director Ramon “Monchi” Rodriguez, who now works for Italian club AS Roma, wrote on Twitter. “Where you are, they never give up.”
Sevilla has not said how Berizzo’s condition will affect his work. In its brief statement, the club said only that further tests will determine what type of treatment will be required. It was not clear if Berizzo will need to undergo surgery.
Sevilla’s next is a league match at Villarreal on Sunday.
Berizzo was hired by Sevilla this season after Jorge Sampaoli left to coach Argentina’s national team. He had spent three seasons with Celta Vigo, guiding the club to the Europa League semifinals and to two Copa del Rey semifinals.
Berizzo was among those jeered on Tuesday after Sevilla conceded three goals in the first 30 minutes of the Group E match against Liverpool in Seville. But Pizarro’s late goal from a corner kick salvaged the draw that kept the club in good position to advance to the knockout stages.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
